IMC Chicago
MDGL icon

IMC Chicago’s Madrigal Pharmaceuticals MDGL Stock Holding History

IMC Chicago’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
23,100
+6,300
+38% +$3.01M ﹤0.01% 1134
2025
Q4 		$9.78M Buy
+16,800
New +$8.58M ﹤0.01% 1240
2023
Q2 		– Sell
-11,500
Closed -$2.79M – 1356
2023
Q1 		$2.79M Sell
11,500
-19,300
-63% -$5.26M ﹤0.01% 762
2022
Q4 		$8.94M Buy
+30,800
New +$3.01M 0.01% 475

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IMC Chicago's MDGL Position: Q1 2026 in Review

IMC Chicago reduced its Madrigal Pharmaceuticals (MDGL) stake by 35% in Q1 2026, selling an estimated $2.03M and leaving 7,795 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

IMC Chicago first reported a position in MDGL in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.02M in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • IMC Chicago held 7,795 shares of Madrigal Pharmaceuticals worth $4.08M as of Q1 2026.
  • IMC Chicago sold 4,256 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $2.03M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1964 holding.
  • IMC Chicago first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Madrigal Pharmaceuticals position peaked at $7.02M in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.